Literature DB >> 28456868

Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients.

Mariana Elizondo-Zertuche1, Alexandra M Montoya1, Efrén Robledo-Leal2, Idalia Garza-Veloz3, Ana L Sánchez-Núñez1, Raquel Ballesteros-Elizondo4, Gloria M González5.   

Abstract

We identified 11 Lomentospora prolificans isolates recovered from Mexican patients using phenotypic and molecular characteristics. The identification of isolates was assessed by internal transcribed spacer (ITS rDNA) sequencing. In vitro susceptibility to amphotericin B, fluconazole, voriconazole, posaconazole, caspofungin, anidulafungin and micafungin was determined according to Clinical and Laboratory Standards Institute (CLSI) procedures. Three isolates (07-2239, 11-2242 and 04-2673) were used to induce systemic infection in immunocompetent ICR mice. Survival and tissue burden studies were used as markers of pathogenicity. All of the strains were resistant to every antifungal tested with MIC's for AmB (8->8 µg/ml), VRC (16->16 µg/ml), PSC (16->16 µg/ml), FLC (64->64 µg/ml) and echinocandins with MICs ≥8 µg/ml. One hundred, ninety and sixty percent of the infected mice with the strains 07-2239, 11-2242 and 04-2673 died during the study, respectively. Regarding tissue burden, the highest fungal load of the infected mice was detected in brain followed by spleen and kidney, regardless of the strain.

Entities:  

Keywords:  In vitro susceptibility; Lomentospora prolificans; Pathogenicity; Survival study; Tissue burden

Mesh:

Substances:

Year:  2017        PMID: 28456868     DOI: 10.1007/s11046-017-0137-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  27 in total

1.  Scedosporium/Pseudallescheria infections.

Authors:  Anil A Panackal; Kieren A Marr
Journal:  Semin Respir Crit Care Med       Date:  2004-04       Impact factor: 3.119

2.  Evaluation of proteolytic activity to differentiate some dematiaceous fungi.

Authors:  A Espinel-Ingroff; P R Goldson; M R McGinnis; T M Kerkering
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

3.  Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation.

Authors:  M Reza Vagefi; Eleanore T Kim; Richard G Alvarado; Jacque L Duncan; Ed L Howes; J Brooks Crawford
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

4.  Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.

Authors:  Montserrat Ortoneda; Javier Capilla; Isabel Pujol; F Javier Pastor; Emilio Mayayo; Joan Fernández-Ballart; Josep Guarro
Journal:  J Antimicrob Chemother       Date:  2002-03       Impact factor: 5.790

5.  In vitro proteinase production by Candida species.

Authors:  A Chakrabarti; N Nayak; P Talwar
Journal:  Mycopathologia       Date:  1991-06       Impact factor: 2.574

6.  PCR-based identification of clinically relevant Pseudallescheria/Scedosporium strains.

Authors:  M Wedde; D Müller; K Tintelnot; G S De Hoog; U Stahl
Journal:  Med Mycol       Date:  1998-04       Impact factor: 4.076

7.  Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits.

Authors:  Javier Capilla; Clara Yustes; Emili Mayayo; Belkys Fernández; Montserrat Ortoneda; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 8.  Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.

Authors:  Juan Luis Rodriguez-Tudela; Juan Berenguer; Josep Guarro; A Serda Kantarcioglu; Regine Horre; G Sybren de Hoog; Manuel Cuenca-Estrella
Journal:  Med Mycol       Date:  2009-06       Impact factor: 4.076

9.  Plate method for detection of phospholipase activity in Candida albicans.

Authors:  M F Price; I D Wilkinson; L O Gentry
Journal:  Sabouraudia       Date:  1982-03

Review 10.  A review of German Scedosporium prolificans cases from 1993 to 2007.

Authors:  K Tintelnot; G Just-Nübling; R Horré; B Graf; I Sobottka; M Seibold; A Haas; U Kaben; G S De Hoog
Journal:  Med Mycol       Date:  2009-03-18       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.